Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

44 results about "Barrier integrity" patented technology

Regulation of barrier integrity during pathological conditions. The significance of the gut barrier in disease pathogenesis has recently attracted attention. Compromised intestinal barrier integrity is observed in both intestinal and systemic diseases, including IBDs, autoimmune diseases, and other metabolic diseases.

Application of oligopeptide in preparation of medicine for treating and / or preventing diabetic nephropathy

The invention discloses application of oligopeptide in preparation of a medicine for treating and / or preventing diabetic nephropathy. The oligopeptides comprise oligopeptides with the amino acid sequence of SEQ ID NO: 1: LNLYP and derivative sequences or conservative substitution variants of the oligopeptides. The oligopeptide can significantly improve renal function indexes of mice with diabetic nephropathy, such as UACR, serum creatinine, urea nitrogen and the like, enhance podocyte barrier integrity and inhibit accumulation of advanced glycosylation end products AGEs in kidney tissues, and provides a basis for development of novel drugs for treating diabetic nephropathy.
Owner:CHINA PHARM UNIV

Lactobacillus rhamnosus JM039 as well as composition and application thereof

The invention belongs to the technical field of probiotic products, and particularly relates to lactobacillus rhamnosus JM039 as well as a composition and application thereof. The preservation number of the lactobacillus rhamnosus JM039 is GDMCC No: 64409. The lactobacillus rhamnosus JM039 is a lactobacillus rhamnosus strain. The composition is prepared from lactobacillus reuteri J1, lactobacillus gasseri JM1, lactobacillus paracasei JY062, lactobacillus paracasei with the preservation number of GDMCC.No.62990, lactobacillus plantarum JY039 and lactobacillus rhamnosus JM039, and is prepared from lactobacillus reuteri J1, lactobacillus gasseri JM1, lactobacillus paracasei JY062, lactobacillus paracasei with the preservation number of GDMCC.No.62990, lactobacillus plantarum The combined bacteria of the six probiotics can improve the levels of anti-inflammatory factors and intestinal epithelium tight junction proteins and reduce the levels of proinflammatory factors and claudin-2 mRNA, so that the intestinal microenvironment homeostasis and intestinal barrier integrity are maintained through double regulation of inflammatory factors and tight junction proteins, and necrotizing enterocolitis can be relieved.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Bifidobacterium bifidum and application thereof in improving asthma and histamine intolerance

ActiveCN119144528AReduce receptor activationreduce remodelingBacteriaAntinoxious agentsBiotechnologyHistamine intolerance
The invention discloses bifidobacterium bifidum and application thereof in improving asthma and histamine intolerance, and belongs to the technical field of marine microorganisms. The bifidobacterium bifidum NHNK-618 is preserved in the China Center for Type Culture Collection on August 9, 2024, and the preservation number of the bifidobacterium bifidum NHNK-618 is CCTCC (China Center for Type Culture Collection) NO: M20241761. The NHNK-618 has the functions of regulating asthma-related flora, agglutinating asthma-related pathogenic bacteria, reducing staphylococcus aureus enterotoxin, reducing bronchial histamine receptor activation, promoting bronchial barrier integrity, reducing airway remodeling and degrading histamine, and in addition, an NHNK-618 thallus biological membrane can improve the colonization capability on intestinal epithelial cells. The compound can be used for preparing products for improving asthma and histamine intolerance.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD

Application of APE1 inhibitor in preparation of medicine for treating nasosinusitis

The invention belongs to the field of small molecule compound medicines, and relates to application of an APE1 inhibitor in preparation of a medicine for treating nasosinusitis. The present application finds a new target APE1 for treating nasosinusitis, and achieves effective treatment of nasosinusitis by an APE1 inhibitor (including a C10 compound), in which the C10 compound shows a very excellent therapeutic effect, significantly inhibits pathological symptoms of nasosinusitis, including relieving Th2 inflammation, reducing eosinophilic granulocyte infiltration, improving nasal barrier integrity damage, and preventing or treating nasosinusitis. And the nasal mucosa neovascularization is prevented by inhibiting the generation of VEGF and other cell factors, and the inflammatory response of chronic nasosinusitis is effectively relieved. In addition, the C10 compound is simple in structure and easy to synthesize, has good patent medicine characteristics, and has good industrialization prospects.
Owner:SHANDONG UNIV QILU HOSPITAL

Preparation method of cochlear organ chip integrated with blood labyrinth barrier

PendingCN120966757ACompound screeningApoptosis detectionEndothelial cell cultureCochlear Organ
The invention discloses a preparation method of a cochlear organ chip integrated with a blood labyrinth barrier, and belongs to the field of biomedical engineering. The preparation method of the simulated blood labyrinth barrier comprises the following steps: constructing an endothelial cell culture cavity and a pericyte culture cavity, and separating the endothelial cell culture cavity and the pericyte culture cavity through a simulated basement membrane; and respectively inoculating percutaneous cells and endothelial cells into a percutaneous cell culture cavity and an endothelial cell culture cavity, and culturing to obtain the simulated blood lost barrier. The chip can effectively simulate the structure and the function of the BLB, and the barrier integrity of the BLB is evaluated through TEER (trans-epithelial electrical resistance) measurement and an apparent permeability coefficient. The invention also relates to application of the chip in NIHL drug screening, in particular to drug evaluation for oxidative stress induced inner ear organ injury. Through the platform, the protection effect of the candidate drugs on the TBHP-induced oxidative stress injury of the inner ear organs can be evaluated, and a new tool and thought are provided for developing novel NIHL treatment drugs.
Owner:SOUTHEAST UNIV

Bifidobacterium longum subsp. Longum and application thereof in improving asthma and high histamine level

ActiveCN119144530ABacteriaDigestive systemBiotechnologyStaphylococcus aureus enterotoxin
The invention discloses bifidobacterium longum subsp. Longum and application thereof in improving asthma and high histamine level, and belongs to the technical field of marine microorganisms. The invention discloses a bifidobacterium longum subsp. Longum NHNK-619, which is preserved in the China Center for Type Culture Collection on August 9, 2024, and the preservation number of the bifidobacterium longum subsp. Longum NHNK-619 is CCTCC (China Center for Type Culture Collection) NO: M20241760. The NHNK-619 has the functions of regulating asthma-related flora, agglutinating asthma-related pathogenic bacteria, reducing staphylococcus aureus enterotoxin, reducing bronchial histamine receptor activation, promoting bronchial barrier integrity, reducing airway remodeling and degrading histamine, and a thallus biofilm formed by the NHNK-619 can improve the colonization ability to intestinal epithelial cells. The compound can be used for preparing products for improving asthma and high histamine level.
Owner:QINGDAO NOVO NUOKANG BIOTECHNOLOGY CO LTD

Application of compound in preparation of medicine for protecting pulmonary vascular endothelial cells

PendingCN121154622AOrganic active ingredientsRespiratory disorderVascular endothelium permeabilityEndothelial permeability
The invention discloses an application of a compound in preparation of a medicine for protecting pulmonary vascular endothelial cells, and relates to the technical field of medicines, the application of the compound in preparation of the medicine for protecting the pulmonary vascular endothelial cells comprises the compound, and the compound is used as an active component of the medicine. The compounds are useful as inhibitors of OSM causing barrier damage to endothelial cells; the compound is used for inhibiting OSM-induced vascular endothelial cell permeability increase in drugs. The compound is used for improving the reduction of vascular epithelial cell membrane electrical impedance caused by OSM in medicines, so that the integrity of a cell barrier is protected; the compound is used for up-regulating vascular endothelial cadherin expression and reducing vascular endothelial permeability in medicines, and repairing vascular endothelial barrier damage caused by OSM. The compound can reverse the reduction of OSM-induced endothelial adhesion connexin and protect the damage of an endothelial barrier, and has a remarkable application prospect in medicines for protecting pulmonary vascular endothelial cells.
Owner:THE THIRD PEOPLES HOSPITAL OF CHENGDU

Lactobacillus fermentum strain from egyptian cheese and its application in inhibiting bacteria and anti-salmonella infection

The application discloses a plant lactobacillus strain and application thereof, and belongs to the technical field of microorganisms. The preservation number of the strain is CGMCC No. 33864. The strain has good tolerance to gastrointestinal juice and bile salts and has no hemolytic activity. Concentrated cell-free supernatant prepared from the strain can inhibit salmonella, including inhibiting the growth of salmonella, killing bacteria, inhibiting or removing biofilm. Animal experiments show that the strain and the concentrated cell-free supernatant thereof can prevent salmonella infection, alleviate weight loss caused by infection, maintain intestinal barrier integrity, reduce the level of pro-inflammatory factors, alleviate tissue damage, improve the expression of colon tight junction proteins and mucin, promote the generation of short-chain fatty acids, and restore the intestinal flora structure. The application further provides a microbial preparation containing the strain and / or the concentrated cell-free supernatant thereof. The strain and the microbial preparation can be used for preparing products for resisting salmonella, preventing salmonella infection or improving intestinal health.
Owner:SOUTHWEST UNIV

Mouse model capable of inductively combining with epithelial cell specific ablation and application thereof

The invention relates to the technical field of biomedicine, and particularly provides a mouse model capable of being inductively combined with epithelial cell specific ablation and application of the mouse model. The method comprises the following steps: inserting a '3xFLAG-P2A-CreERT2 'functional frame at a fixed point at a termination codon of a mouse Odam gene, so as to obtain an OdamCreERT2 mouse. The expression specificity of the Odam gene in binding epithelium is verified by a mouse obtained by copulating with a ROSA26mT / mG reporter gene mouse; mice obtained by mating with ROSA26DTA cell ablation mice reveal the indispensable function of binding epithelium in maintaining periodontal barrier and preventing bone resorption. The model retains endogenous Odam expression and functions, supports protein dynamic tracing and space-time specific gene manipulation, and is suitable for researching the effect of binding epithelium in periodontal barrier integrity and alveolar bone resorption prevention.
Owner:WUHAN UNIV

Probiotic composition, fermented yoghurt and application of probiotic composition and fermented yoghurt in improving related indexes of athletes

The invention discloses a probiotic composition, fermented yoghurt and application of the probiotic composition and the fermented yoghurt in improving related indexes of athletes. The probiotic composition comprises bacillus subtilis SP-8-5, lactobacillus plantarum YM-4-3, lactobacillus plantarum AY01 and pediococcus acidilactici LH01. The composition of intestinal microbial populations can be adjusted through a specific compounding method, the abundance of harmful bacteria is reduced, the abundance of beneficial bacteria is improved, the immunity of intestinal tracts is enhanced, and the integrity of intestinal barriers of athletes is maintained. Meanwhile, the composition has a positive improvement effect on related exercise indexes such as plasma amino acid, excrement metabolites and exercise performance, and can be used as an effective exercise supplement to be applied to athletes.
Owner:朗恒科技集团有限公司 +1

Application of plant lactobacillus BD7807 in preparation of product for treating intestinal barrier dysfunction

The invention relates to the technical field of microorganisms, in particular to application of plant lactobacillus BD7807 in preparation of a product for treating intestinal barrier dysfunction. The product for treating intestinal barrier dysfunction can significantly improve Caco2 cell monolayer barrier injury induced by excessive fatty acid, alleviate body oxidative stress injury and whole body chronic low-degree inflammation caused by high fat diet, significantly enhance expression of tight junction genes and activity of proteins, enhance integrity of intestinal epithelial barrier, and improve the intestinal barrier dysfunction. And the market prospect is wide.
Owner:BRIGHT DAIRY & FOOD CO LTD

Methods and systems for multimodal measurement, forecasting, and modulation of aqueous outflow

ActiveUS12681004B1Schlemm's canalAqueous outflow
A system and method for measuring, forecasting, and modulating aqueous outflow is described here. The system and method operate on an ocular microphysiological system that reproduces the trabecular-meshwork-membrane-Schlemm's canal interface under a defined hydrodynamic program. The signals may include TEER resistance, pressure-flow measurements, OCT / OCTA images, and Raman spectra. The Ocular MPS system may include encoding the multimodal signals into a device-agnostic feature representation that includes descriptors of junction continuity, belt thickness, tortuosity, pathway activity, and outflow-resistance proxies. The Ocular MPS system may execute a physics-informed graph state-space model that fuses the device-agnostic feature representation into inferred parameters. The inferred parameters may be inferred from barrier integrity, permeability, and outflow facility, subject to monotonic constraints between structural and hydraulic variables. The Ocular MPS system may quantify uncertainty of inferred parameters, generating calibrated forecasts of aqueous outflow performance. The Ocular MPS system may control a drive actuator according to the calibrated forecasts.
Owner:REYNARD MICHAEL

Composition and application thereof in preparation of product for relieving diarrhea

The invention relates to the technical field of feed products, in particular to a composition and application thereof in preparation of a product for relieving diarrhea. The composition of the present invention comprises butyric acid, lauric acid, arachidonic acid, docosahexaenoic acid and eicosapentaenoic acid, or a precursor substance capable of releasing the aforementioned fatty acids in the digestive tract. The composition provided by the invention can effectively relieve diarrhea and inflammation, regulate intestinal flora and improve intestinal barrier integrity and intestinal health, and is used for preventing, relieving or treating intestinal diseases; the composition has an obvious relieving effect on diarrhea and enteritis of animals, compared with drugs such as antibiotics, the composition has higher safety and is not prone to drug resistance, and the composition can be used for treating intestinal diseases and can also be added into daily ration to improve intestinal health.
Owner:CABIO BIOTECH (WUHAN) CO LTD +2

Probiotic compositions and methods for preventing muscle loss in individuals

PCT designated stageWO2026150009A1BiotechnologyProbiotic bacterium
The present invention relates to probiotic compositions comprising at least one Lactobacillus helveticus, at least one Bifidobacterium longum, and at least one Bifidobacterium animalis. The present invention further relates to methods of using said compositions for preventing muscle loss, improving or maintaining muscle strength, and maintaining intestinal barrier integrity.
Owner:DANSTAR FERMENT AG

Umbilical cord mesenchymal stem cells, preparation method and application thereof

The application belongs to the technical field of biological medicine, and particularly relates to umbilical cord mesenchymal stem cells and a preparation method and application thereof. The preparation method takes umbilical cord Wharton's jelly as raw material, and obtains high-purity umbilical cord mesenchymal stem cells through cleaning treatment, tissue block preparation, serum-free culture and liquid change subculture. The culture conditions and operation parameters are strictly controlled in the preparation process, the MSC serum-free culture medium and trypsin substitutes are used, so that the cell activity and purity can be guaranteed. The umbilical cord mesenchymal stem cells have no obvious toxicity and tumorigenic risk under a safe dose, and have no damage to organs in long-term use. The umbilical cord mesenchymal stem cells can significantly improve the motor dysfunction after cerebral ischemia, reduce the volume of cerebral ischemic injury, protect the integrity of the blood-brain barrier, reduce the neuroinflammatory response, and play a multi-dimensional role in brain tissue protection and repair, thereby providing a new effective means for the treatment of ischemic stroke, and having important clinical transformation value and application prospect.
Owner:HEILONGJIANG GUOZHI BIOENGINEERING CO LTD

Application of Roseburia inulinivorans in preparation of medicine for treating enteritis

The invention belongs to the technical field of biological agents, and particularly relates to application of Roseburia inulinivorans in preparation of a medicine for treating and / or preventing enteritis. The invention finds that the intestinal bacteria Roseburia inulinivorans can improve ulcerative colitis by adjusting the steady state of microorganisms, protecting the integrity of intestinal barriers and maintaining the steady state of immunity. According to the application, the curative effect of Roseburia inulinivorans on colitis is comprehensively evaluated, and the Roseburia inulinivorans has the functions of resisting inflammation, recovering immune balance, resisting oxidative stress, resisting pyroptosis, regulating bile acid metabolism, relieving endothelial dysfunction and intestinal ecological dysfunction and the like, and particularly, the Roseburia inulinivorans can achieve the treatment effect the same as that of a clinical conventional medicine mesalazine. And meanwhile, the Roseburia inulinivorans has no side effects, so that the Roseburia inulinivorans have no side effects. Therefore, the Roseburia inulinivorans is very likely to become a good candidate drug for improving the ulcerative colitis.
Owner:康永波

Biological detection system and method for determining barrier integrity of environmental pollutants

PendingCN120161092AMaterial resistanceTranscellularChemical compound
The invention belongs to the technical field of biological barrier integrity, and provides a biological detection system for measuring the barrier integrity of environmental pollutants. The system is characterized by comprising a trans-cell membrane resistance instrument which comprises an EVOM single-value current probe, an STX2 electrode and a resistance reader; the plurality of biological components comprise primary cell lines, test cups and culture ponds for placing the test cups; and the electric wire is used for connecting the trans-cell membrane resistance instrument and the biological barrier detection cell assembly to form a closed loop. According to the biological detection method for determining the barrier integrity of the environmental pollutants, the range of detectable compounds can be expanded, the detection time can be shortened, the detection process is simplified, and the universality of the detection method is improved.
Owner:SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI

Method for promoting intestinal absorption of dihydroquercetin by using quercetin, composition and application of composition

The invention relates to the technical field of biological medicines, and particularly discloses a method and a composition for promoting intestinal absorption of dihydroquercetin by using quercetin and application of the method and the composition, and the method comprises the following steps: jointly applying an effective amount of dihydroquercetin and an effective amount of quercetin serving as a synergist to an intestinal environment; wherein the quercetin plays a role through at least one of the following mechanisms: inhibiting the function or expression of P-glycoprotein in intestinal epithelial cells; the tight connection of intestinal epithelial cells is regulated. It is found that quercetin not only can effectively inhibit the excretion function of P-glycoprotein in intestinal epithelial cells, but also can enhance the integrity of intestinal barriers by down-regulating the expression level of the protein and up-regulating the expression of tight junction protein, so that intestinal absorption of dihydroquercetin is synergistically promoted from the multi-mechanism level; in addition, the composition can still maintain a good absorption promoting effect in an inflammatory environment, and shows a synergistic anti-inflammatory effect.
Owner:HAINAN UNIV

Application of radix puerariae exosome-shaped vesicles in preparation of medicine for preventing and / or treating ulcerative colitis and related colorectal cancer thereof

The invention belongs to the field of medicine and health, and particularly relates to application of fresh traditional Chinese medicine radix puerariae exosome-shaped vesicles P-ELNs in medicine or health food for preventing and treating irritable bowel syndrome, the P-ELNs serving as an active ingredient can improve expression of colonic intestinal mucus protein MUC2 and tight junction protein ZO-1 and improve mucous membrane barrier integrity; the inhibition of the expression level of proinflammatory factors (such as TNF-alpha, IL-6, IL-1beta and NF-kappa B) indicates that the action mechanism may involve the synergistic effect of inflammation inhibition and barrier repair. Toxicological experiments show that the P-ELNs have no toxicity after long-term intragastric administration, have no adverse effects on heart, liver, spleen, lung and kidney functions, and have good oral safety and tissue tolerance. The indications comprise anti-inflammatory treatment of active-stage UC patients; maintenance and barrier repair of patients in the UC remission period; the UC disease course is more than or equal to 8 years, and a preventive medicine is applied to high-risk people with cancerization family history and the like; the invention relates to auxiliary treatment of UC-CAC early cancerization patients.
Owner:CHONGQING UNIVERSITY THREE GORGES HOSPITAL

Application of compound tung leaf burn oil in preparation of medicine for treating colitis

The invention discloses application of compound tung leaf burn oil in preparation of a medicine for treating colitis. The compound tung leaf burn oil disclosed by the invention can show the effect of improving ulcerative colitis (UC) only when the compound tung leaf burn oil is used as an active substance independently or together with other medicine components. The compound tung leaf burn oil not only can up-regulate the expression of tight junction proteins ZO-1, Occludin and Claudin-1 in the intestinal tract and maintain the integrity of the barrier, but also can down-regulate the expression of proinflammatory mediators such as TNF-alpha, TLR4 and IL-18 in serum and improve the expression level of an anti-inflammatory factor IL-4, so that the inflammation of the intestinal tract and the organism is relieved, and the barrier function of the intestinal tract is effectively repaired. In addition, the compound tung leaf burn oil can also effectively relieve intestinal flora disorder caused by DSS and maintain the intestinal steady state.
Owner:XIANGXI HONGCHENG PHARMA

Use of phosphatidylcholine in the preparation of a medicine for preventing and treating porcine rotavirus infection

The application belongs to the technical field of biological medicine, and particularly relates to application of phosphatidylcholine in preparation of a medicine for preventing and treating porcine rotavirus infection. The application finds that phosphatidylcholine (PC) has significant antiviral activity in preventing and treating PoRVA infection. Experimental results show that PC can effectively inhibit PoRVA proliferation, reduce viral load, and then relieve diarrhea symptoms caused by PoRVA infection and reduce mortality. In addition, PC can also inhibit necrotic apoptosis induced by PoRVA infection, promote repair and maintenance of intestinal barrier integrity, reduce intestinal tissue damage, and reduce the risk of secondary infection. The above results show that PC has good therapeutic potential for PoRVA infection. At the same time, PC is safe in source, has good biocompatibility, and no obvious toxic side effects are observed within a reasonable dose range, and is suitable for prevention and / or treatment of PoRVA infection, and has good application prospect and popularization value.
Owner:SUN YAT SEN UNIV

Application of water-soluble fullerene nano-material in preparation of medicine for treating and / or relieving endotoxemia

The invention discloses an application of a water-soluble fullerene nano material in preparation of a medicine for treating and / or relieving endotoxemia. The method for treating and / or relieving the endotoxemia comprises the following steps: 1) inhibiting inflammation caused by the endotoxemia; 2) the intestinal epithelial barrier is protected or intestinal epithelial barrier injury caused by endotoxemia is relieved; the inventor of the invention discovers that the water-soluble fullerene blocks the pyroptosis of macrophages induced by inflammation by down-regulating the expression of gasdermin D (N-GSDMD) after cutting for the first time. The AFRM repairs epithelium connection and extracellular matrix, and reduces oxidative damage to intestinal epithelial barrier. The AFRM with broad-spectrum and self-cascade redox regulation characteristics can be used for remodeling the intestinal microenvironment in three aspects of relieving excessive inflammation, inhibiting pyroptosis of macrophages and maintaining the integrity of the intestinal epithelial barrier, so that multi-target synergistic efficient treatment on the LPS-induced endotoxemia is realized.
Owner:INST OF CHEM CHINESE ACAD OF SCI

The composition comprises bifidobacterium longum subsp. Infantis, bifidobacterium breve and 2apos; composition of fucosyllactose

The present disclosure relates generally to a composition comprising a Bifidobacterium longum subsp. Infantis preserved in the form of DSM 15953 (Bifidobacterium longum subsp. Infantis), a Bifidobacterium breve (Bifidobacterium breve) preserved in the form of DSM 34541 (Bifidobacterium breve), and 2 '-fucosyllactose (2' FL). The present disclosure relates generally to a composition comprising: Bifidobacterium longum subsp. Infantis preserved in the form of DSM 34541 (Bifidobacterium breve); the use of the compositions in supporting gastrointestinal health, including promoting intestinal barrier integrity and growth of beneficial microbiota in the gastrointestinal tract, while also having beneficial effects on immune function is also part of the present disclosure.
Owner:CHR HANSEN AS

Application of rhizoma polygonati water extract in preparation of medicine for treating acute appendicitis

The invention discloses an application of a rhizoma polygonati water extract in preparation of a medicine for treating acute appendicitis. The rhizoma polygonati water extract provided by the invention can be used for remarkably improving clinical symptoms of appendicitis, effectively protecting mechanical barrier integrity of intestinal mucosa and relieving inflammatory response. According to the invention, the treatment effect of the rhizoma polygonati water extract on acute appendicitis is defined for the first time, the application blank of traditional Chinese medicines in the field is filled, and a scientific basis is provided for subsequent development of similar medicines by revealing the action mechanism (such as regulation and control of tight junction proteins and inflammatory factors) of the rhizoma polygonati water extract; the method has important value in the theoretical research level and the application and popularization aspects.
Owner:EASTERN GANSU UNIVERSITY +1

A beta-targeting peptide-functionalized cellulose derivative, and a preparation method and application thereof

The application discloses a kind of peptide functionalized cellulose derivatives targeting A beta and its preparation method and application, belong to the field of biological medicine technology.The peptide functionalized cellulose derivative obtained by connecting A beta targeting peptide with hydroxypropyl cellulose through ester bond can be combined with A beta protein through molecular recognition specificity, and self-assembly is formed into core-shell structure nanomicelle, A beta oligomer is efficiently encapsulated, A beta aggregation and fiberization are inhibited, meanwhile, the interaction between A beta and endothelial cell junction protein is blocked by anti-fouling performance, APEL effect induced by amyloid is inhibited, and the integrity of blood-brain barrier is protected.In addition, the peptide functionalized cellulose derivative has good biocompatibility, can reduce A beta plaque deposition in brain, improve the cognitive function of AD patients, and provides a new type of efficient candidate drug for the treatment of Alzheimer's disease.
Owner:HUBEI UNIV

The composition comprises a bifidobacterium animalis subsp. Lactis strain and 2apos; composition of fucosyllactose

In particular, the present disclosure relates to a composition comprising a Bifidobacterium animalis subsp. Lactis strain (Bifidobacterium animalis subsp. Lactis), which is preserved as DSM 15954 by the Deutsche Sammneck von Microorganism strain preservation center (Deutsche Sammneck von Microorganism strain GmbH, DSMZ), and 2 '-fucosyllactose (2' FL), and to a method for preparing the same. The present disclosure also relates to a composition that also comprises a strain of Bifidobacterium longum subsp. Infantis, which is preserved as DSM 15953, and to a method for producing the same. The present disclosure also relates to a composition that also comprises a strain of Bifidobacterium longum subsp. Infantis, which is preserved as DSM 15953. The use of the compositions in supporting gastrointestinal health, including promoting intestinal barrier integrity and growth of beneficial microbiota in the gastrointestinal tract, while also having beneficial effects on immune function is also part of the present disclosure.
Owner:CHR HANSEN AS

An optimized IL-21 gene of grass carp, its encoded recombinant protein, recombinant plasmid, and its recombination methods and applications.

This invention relates to the fields of molecular biology and biomedicine, specifically to a method and application of recombinant methods for the grass carp IL-21 optimized gene, its recombinant protein, and plasmids. The recombinant protein of this invention is a mature grass carp IL-21 peptide. The pET-28a-IL-21 recombinant expression plasmid was constructed by optimizing the IL-21 base codons, transformed into an *E. coli* (DE3) expression system, and soluble grass carp IL-21 recombinant protein was obtained by IPTG induction. Furthermore, this invention also found that the optimized gene, its recombinant protein, and plasmids can enhance the intestinal barrier integrity of grass carp, inhibit the load of pathogenic bacteria in the intestine, and repair intestinal damage caused by bacterial infection. This indicates that the grass carp IL-21 recombinant protein has a significant effect on protecting intestinal homeostasis, highlighting its promising application prospects in the research and development of prevention and treatment of bacterial enteritis in aquatic animals.
Owner:XINYANG AGRI & FORESTRY UNIV

In vitro method for assessing and / or monitoring the degree of intestinal barrier integrity and / or permeability in a subject

PCT designated stageWO2026234294A1Biological testingBarrier integrityIntestino-intestinal
The present invention refers to an in vitro method for assessing and / or monitoring the degree of intestinal barrier integrity and / or permeability in a subject.
Owner:VENTER PHARMA

Compositions and uses thereof

The present invention relates to a composition for use in improving the gastrointestinal microbiota, and maintaining and / or improving gut barrier integrity in an individual, the composition comprising the combination of xylooligosaccharides (XOS) and inulin. A method of preparing said composition and the use of said composition as a dietary supplement or a medicament are also disclosed.
Owner:OPTIBIOTIX

Natural self-assembled hydrogel based on antioxidant, anti-inflammatory and intestinal barrier repair functions and application thereof in treatment of inflammatory bowel disease

The invention provides a carrier-free GMR hydrogel drug formed by self-assembly of natural active components glycyrrhizic acid (GA) and rosmarinic acid (RA) mediated by Mg < 2 + >, and the carrier-free GMR hydrogel drug is used for treating inflammatory bowel disease (IBD). The hydrogel medicine is simple in preparation method and good in gelation property. In animal models of ulcerative colitis and Crohn's disease, the GMR hydrogel shows remarkable prevention and treatment effects. The action mechanism of the compound is mainly derived from a cell protection effect, mitochondrial damage caused by oxidative stress can be relieved, and an NLRP3 / caspase-1 / GSDMD mediated pyroptosis pathway in intestinal epithelial cells is inhibited. Meanwhile, the hydrogel can restore the integrity of the intestinal barrier by up-regulating tight junction protein, and can play a comprehensive therapeutic effect on IBD by remodeling intestinal flora, enhancing the diversity of the flora and promoting the generation of short-chain fatty acid. In addition, the GMR hydrogel shows good biological safety and a simple and convenient preparation process, so that the hydrogel based on a natural product is expected to become an IBD treatment strategy with a wide application prospect.
Owner:BEIJING UNIV OF CHINESE MEDICINE